Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Solveig Hofvind

Showing results (171-180 of 228) with videos related to

Pageof 23
Sort By:
The Lancet. Oncology|August 4, 2023
Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy studyKristina Lång, Viktoria Josefsson, Anna-Maria Larsson, et al.
Radiology|February 20, 2019
Digital Mammography versus Digital Mammography Plus Tomosynthesis in Breast Cancer Screening: The Oslo Tomosynthesis Screening TrialPer Skaane, Andriy I Bandos, Loren T Niklason, et al.
European Radiology|June 18, 2026
Location of AI risk markers and associated mammographic features in screening mammograms obtained years before screen-detected breast cancerMarit A Martiniussen, Marie B Bergan, Merete U Kristiansen, et al.
Journal of Medical Screening|March 15, 2021
Assessment of breast positioning criteria in mammographic screening: Agreement between artificial intelligence software and radiographersGunvor G Waade, Anders Skyrud Danielsen, Åsne S Holen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 12, 2022
Oncological outcomes after simple and skin-sparing mastectomy of ductal carcinoma in situ: A register-based cohort study of 576 Norwegian womenHelle Kristine Skjerven, Even Moa Myklebust, Christian Korvald, et al.
The Lancet. Digital Health|February 4, 2025
Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy studyVeronica Hernström, Viktoria Josefsson, Hanna Sartor, et al.
Journal of Medical Screening|September 27, 2019
Screening at stationary versus mobile units in BreastScreen NorwayÅsne Holen, Sofie Sebuødegård, Gunvor G Waade, et al.
Radiology. Artificial Intelligence|May 13, 2026
Artificial Intelligence for Digital Breast Tomosynthesis Screening with and without prior Examinations in BreastScreen NorwayNataliia Moshina, Marthe Larsen, Åsne S Holen, et al.
The Lancet. Oncology|May 13, 2019
Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trialSolveig Hofvind, Åsne S Holen, Hildegunn S Aase, et al.
European Journal of Radiology|September 14, 2023
Early screening outcomes before, during, and after a randomized controlled trial with digital breast tomosynthesisÅsne Sørlien Holen, Marie Burns Bergan, Christoph I Lee, et al.
Pageof 23

Showing results (171-180 of 228) with videos related to

Sort By:
Pageof 23
The Lancet. Oncology|August 4, 2023
Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy studyKristina Lång, Viktoria Josefsson, Anna-Maria Larsson, et al.
Radiology|February 20, 2019
Digital Mammography versus Digital Mammography Plus Tomosynthesis in Breast Cancer Screening: The Oslo Tomosynthesis Screening TrialPer Skaane, Andriy I Bandos, Loren T Niklason, et al.
European Radiology|June 18, 2026
Location of AI risk markers and associated mammographic features in screening mammograms obtained years before screen-detected breast cancerMarit A Martiniussen, Marie B Bergan, Merete U Kristiansen, et al.
Journal of Medical Screening|March 15, 2021
Assessment of breast positioning criteria in mammographic screening: Agreement between artificial intelligence software and radiographersGunvor G Waade, Anders Skyrud Danielsen, Åsne S Holen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 12, 2022
Oncological outcomes after simple and skin-sparing mastectomy of ductal carcinoma in situ: A register-based cohort study of 576 Norwegian womenHelle Kristine Skjerven, Even Moa Myklebust, Christian Korvald, et al.
The Lancet. Digital Health|February 4, 2025
Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy studyVeronica Hernström, Viktoria Josefsson, Hanna Sartor, et al.
Journal of Medical Screening|September 27, 2019
Screening at stationary versus mobile units in BreastScreen NorwayÅsne Holen, Sofie Sebuødegård, Gunvor G Waade, et al.
Radiology. Artificial Intelligence|May 13, 2026
Artificial Intelligence for Digital Breast Tomosynthesis Screening with and without prior Examinations in BreastScreen NorwayNataliia Moshina, Marthe Larsen, Åsne S Holen, et al.
The Lancet. Oncology|May 13, 2019
Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trialSolveig Hofvind, Åsne S Holen, Hildegunn S Aase, et al.
European Journal of Radiology|September 14, 2023
Early screening outcomes before, during, and after a randomized controlled trial with digital breast tomosynthesisÅsne Sørlien Holen, Marie Burns Bergan, Christoph I Lee, et al.
Pageof 23